1. Home
  2. CAST vs BDSX Comparison

CAST vs BDSX Comparison

Compare CAST & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreeCast Inc. Class A Common Stock

CAST

FreeCast Inc. Class A Common Stock

N/A

Current Price

$1.33

Market Cap

162.3M

Sector

Technology

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$27.45

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAST
BDSX
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.3M
153.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
CAST
BDSX
Price
$1.33
$27.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$6.00
$32.50
AVG Volume (30 Days)
8.1M
119.9K
Earning Date
06-26-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.50
$0.35
52 Week High
$12.20
$31.31

Technical Indicators

Market Signals
Indicator
CAST
BDSX
Relative Strength Index (RSI) 43.28 59.35
Support Level $0.67 $19.26
Resistance Level $1.99 N/A
Average True Range (ATR) 0.34 2.42
MACD 0.08 0.37
Stochastic Oscillator 32.05 60.53

Price Performance

Historical Comparison
CAST
BDSX

About CAST FreeCast Inc. Class A Common Stock

FreeCast Inc is a streaming technology company that provides platform-as-a-service solutions for television and digital video distribution. Its platform infrastructure supports telecom operators, internet service providers, broadcasters, municipalities, utilities, brands, and device manufacturers in deploying and managing digital media and streaming services.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: